Skip to main content

Table 2 Presentation of characteristics (age, sex, localization) of IBD patients at diagnosis and the frequency of suggestive imaging findings, overall and in ulcerative colitis and Crohn’s disease separately

From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

  Total number of IBD patients Patients with Ulcerative colitis Patients with Crohn’s disease
Severity at diagnosis of IBD   According to MAYO score
48% (166/346) Mild
29% (100/346) Moderate
23% (80/346) Severe
According to CDAI score
27% (69/256) Mild
41% (105/256) Moderate
32% (82/256) Severe
Localization   24% (83/346) Proctitis
41% (142/346) Left sided colitis
35% (121/346) Pancolitis
29% (74/256) Ileitis
38% (97/256) Colitis
33% (85/256) Ileitis and colitis
Age at diagnosis 39 (Std. Dev. 17.4) 42 (Std. Dev. 18.9) 35 (Std. Dev. 16.3)
Sex (Male/Female) 360 (60%)/ 242 (40%) 202 (58%) /144 (42%) 162 (63%) /94 (37%)
Fatty liver 44 (20%, 44/220) 28 (26.2%, 28/107) 16 (14.2%, 16/113)
Hemangioma 11 (5%, 11/220) 7 (6.5%, 7/107) 4 (3.5%, 4/113)
Cyst 14 (6.3%, 14/220) 8 (7.5%, 8/107) 6 (5.3%, 6/113)
Multiple liver abscesses 1 (0.4%, 1/220) 0 (0%) 1 (0.9%, 1/113)
Fibrosis 1 (0.4%, 1/220) 0 (0%) 1 (0.9%, 1/113)
Cirrhosis 1 (0.4%, 1/220) 0 (0%) 1 (0.9% 1/113)
Portal vein thrombosis 1 (0.4%, 1/220) 1 (0.9%, 1/107) 0 (0%)
Cholelithiasis 32 (14.5%, 32/220) 12 (11.2%, 12/107) 20 (17.7%, 20/113)
Primary sclerosing cholangitis 7 (3.2%, 7/220) 2 (1.9%, 2/107) 5 (4.4%, 5/113)
Cholecystitis 7 (3.2%, 7/220) 3 (2.8%, 3/107) 4 (3.5%, 4/113)
Polyps in the gallbladder 5 (2.3%, 5/220) 4 (3.7%, 4/107) 1 (0.9%, 1/113)
Cholangiocarcinoma 1 (0.4%, 1/220) 1 (0.9%, 1/107) 0 (0%)
Acute pancreatitis 4 (1.8%, 4/220) 0 (0%) 4 (3.5%, 4/113)
Fatty pancreas 2 (0.9%, 2/220) 1 (0.9%, 1/107) 0 (0%)
Chronic pancreatitis 1 (0.4%, 1/220) 1 (0.9%, 1/107) 0 (0%)